Clinical trial Recruiting at 2 sites Observational Ages 18 to 75

Building prospective, pan‑cancer pathology AI models

Official title: Development and Clinical Application of Deep Learning-Based Prospective Pathology Foundation Models

Run by Nanfang Hospital, Southern Medical University · NCT07157618 · Data updated 2026-11-12

This project will test whether AI models trained on new pathology images and clinical data can help improve diagnosis and treatment guidance for adults with cancer.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment2000 (estimated)
SponsorNanfang Hospital, Southern Medical University
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Guangzhou, Guangdong and 1 other locations)
StatusRecruiting
StartedAugust 28, 2025
Main results expectedJuly 2028
Study endsAugust 2028
Registry record updatedApril 23, 2026
Trial IDNCT07157618 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with complete pathological slides and linked clinical information for their cancer are ideal candidates.

Probably not a fit

Patients outside the 18–75 age range or those with missing data or specimens that fail quality control are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project prospectively collects histopathology slides and linked clinical data across multiple cancer types to train large deep‑learning 'foundation' pathology models. These models are intended to support tasks such as tumor grading, histo‑molecular classification, and intelligent chemotherapy guidance by learning from real-world, forward‑looking clinical samples. The approach uses standardized quality control of specimens and centralized model development using data from participating hospitals. The goal is to produce models that are validated on prospectively acquired data rather than only on retrospective archives.

Why it matters

Potential benefit: If successful, these models could speed up and improve diagnostic accuracy, provide additional molecular and treatment guidance from routine slides, and reduce workload on pathologists.

How similar studies have gone: Retrospective deep‑learning studies on histopathology have shown promising results, but prospectively validated, pan‑disease foundation pathology models remain largely novel and unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 18-75 years old.
2. Patients with complete pathological slides and clinical information.

Exclusion Criteria:

1.Patients with missing data or specimens not meeting quality control requirements for analysis.

Where it's running

  • Nanfang Hospital, Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting
  • Qianfoshan Hospital
    Jinan, Shandong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.